Literature DB >> 26092878

The controversy surrounding the use of whole-brain radiotherapy in brain metastases patients.

Minesh P Mehta1.   

Abstract

Entities:  

Keywords:  brain radiotherapy; cancer; memory; metastasis

Mesh：

Year:  2015        PMID： 26092878      PMCID： PMC5762013          DOI： 10.1093/neuonc/nov089

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  20 in total

1.  Roentgen-ray therapy of cerebral metastases.

Authors:  J H CHAO; R PHILLIPS; J J NICKSON
Journal:  Cancer       Date:  1954-07       Impact factor: 6.860

2.  The dandelion effect: treat the whole lawn or weed selectively?

Authors:  Minesh Mehta
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

3.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

4.  Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases.

Authors:  Hideki Ogiwara; Kapila Kalakota; Sunpreet S Rakhra; Irene B Helenowski; Maryanne H Marymont; John A Kalapurakal; Minesh P Mehta; Robert B Levy; James P Chandler
Journal:  J Neurooncol       Date:  2012-03-18       Impact factor: 4.130

5.  Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.

Authors:  Vinai Gondi; Stephanie L Pugh; Wolfgang A Tome; Chip Caine; Ben Corn; Andrew Kanner; Howard Rowley; Vijayananda Kundapur; Albert DeNittis; Jeffrey N Greenspoon; Andre A Konski; Glenn S Bauman; Sunjay Shah; Wenyin Shi; Merideth Wendland; Lisa Kachnic; Minesh P Mehta
Journal:  J Clin Oncol       Date:  2014-10-27       Impact factor: 44.544

6.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul D Brown; Stephanie Pugh; Nadia N Laack; Jeffrey S Wefel; Deepak Khuntia; Christina Meyers; Ali Choucair; Sherry Fox; John H Suh; David Roberge; Vivek Kavadi; Soren M Bentzen; Minesh P Mehta; Deborah Watkins-Bruner
Journal:  Neuro Oncol       Date:  2013-08-16       Impact factor: 12.300

Review 7.  Strategies for preservation of memory function in patients with brain metastases.

Authors:  Nicholas B Dye; Vinai Gondi; Minesh P Mehta
Journal:  Chin Clin Oncol       Date:  2015-06

Review 8.  The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Laurie E Gaspar; Minesh P Mehta; Roy A Patchell; Stuart H Burri; Paula D Robinson; Rachel E Morris; Mario Ammirati; David W Andrews; Anthony L Asher; Charles S Cobbs; Douglas Kondziolka; Mark E Linskey; Jay S Loeffler; Michael McDermott; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

9.  Prophylactic cranial irradiation in extensive small-cell lung cancer.

Authors:  Ben Slotman; Corinne Faivre-Finn; Gijs Kramer; Elaine Rankin; Michael Snee; Matthew Hatton; Pieter Postmus; Laurence Collette; Elena Musat; Suresh Senan
Journal:  N Engl J Med       Date:  2007-08-16       Impact factor: 91.245

10.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316
View more
  9 in total

1.  The rapidly evolving treatment landscape for patients with brain metastases from epidermal growth factor receptor mutated non-small cell lung cancer.

Authors:  Anthony M Brade
Journal:  Transl Lung Cancer Res       Date:  2017-12

2.  ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases.

Authors:  Debu Tripathy; Sara M Tolaney; Andrew D Seidman; Carey K Anders; Nuhad Ibrahim; Hope S Rugo; Chris Twelves; Veronique Dieras; Volkmar Müller; Mary Tagliaferri; Alison L Hannah; Javier Cortés
Journal:  Future Oncol       Date:  2019-05-10       Impact factor: 3.404

3.  Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Stefano Tomatis; Anna M Ascolese; Ciro Franzese; Luca Toschi; Armando Santoro; Fiorenza De Rose; Davide Franceschini; Lorenzo Bello; Marta Scorsetti
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

Review 4.  Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues.

Authors:  Arjun Sahgal; Mark Ruschin; Lijun Ma; Wilko Verbakel; David Larson; Paul D Brown
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

5.  The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis.

Authors:  Eva Elisabeth van Grinsven; Steven H J Nagtegaal; Joost J C Verhoeff; Martine J E van Zandvoort
Journal:  Oncol Res Treat       Date:  2021-09-03       Impact factor: 2.825

Review 6.  Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.

Authors:  Ayal A Aizer; Nayan Lamba; Manmeet S Ahluwalia; Kenneth Aldape; Adrienne Boire; Priscilla K Brastianos; Paul D Brown; D Ross Camidge; Veronica L Chiang; Michael A Davies; Leland S Hu; Raymond Y Huang; Timothy Kaufmann; Priya Kumthekar; Keng Lam; Eudocia Q Lee; Nancy U Lin; Minesh Mehta; Michael Parsons; David A Reardon; Jason Sheehan; Riccardo Soffietti; Hussein Tawbi; Michael Weller; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

Review 7.  Updates in the management of brain metastases.

Authors:  Nils D Arvold; Eudocia Q Lee; Minesh P Mehta; Kim Margolin; Brian M Alexander; Nancy U Lin; Carey K Anders; Riccardo Soffietti; D Ross Camidge; Michael A Vogelbaum; Ian F Dunn; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2016-08       Impact factor: 12.300

8.  Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases.

Authors:  Ágnes Dobi; Emese Fodor; Anikó Maráz; Zsófia Együd; Adrienne Cserháti; László Tiszlavicz; Zita Reisz; Pál Barzó; Zoltán Varga; Katalin Hideghéty
Journal:  Pathol Oncol Res       Date:  2018-01-17       Impact factor: 3.201

Review 9.  BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy.

Authors:  Mudit Chowdhary; Kirtesh R Patel; Hasan H Danish; David H Lawson; Mohammad K Khan
Journal:  Onco Targets Ther       Date:  2016-12-12       Impact factor: 4.147
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.